Pia Holmgaard

Cardiovascular Events, Acute Hospitalizations, and Mortality in Patients With Type 2 Diabetes Mellitus Who Initiate Empagliflozin Versus Liraglutide: A Comparative Effectiveness Study

Reimar W. Thomsen, Jakob S. Knudsen, Johnny Kahlert et al. · Journal of the American Heart Association · 2021 · 27 citations · Full text

The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease

Lars Holger Ehlers, Mark Lamotte, Sofia Monteiro et al. · Diabetes Therapy · 2021 · 17 citations · Full text

The cost–effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark

Lars Holger Ehlers, Mark Lamotte, Mafalda Ramos et al. · Journal of Comparative Effectiveness Research · 2021 · 11 citations · Full text

The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark

Lars Holger Ehlers, Mark Lamotte, Mafalda Ramos et al. · Diabetes Therapy · 2022 · 10 citations · Full text